StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$923.34−22.19 (-2.35%)

Close on Nov 19, 2026Market cap $95.52BP/E 20.4Yield –

Regeneron Pharmaceuticals Customer Accounts Receivable Concentration by Year

Customer Accounts Receivable Concentration — Top Specialty Distributors Share of Trade AR [annual] (%) (%)

Regeneron Pharmaceuticals Customer Accounts Receivable Concentration: 8,700.0% in FY2025, up 800.0 pts from a year earlier.

Latest, FY2025
8,700.0%
Period ended Dec 31, 2025
Change on a year earlier
+800.0 pts
7,900.0% in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-04) ↗

Reported in Form 10-K Note — Concentration of Credit Risk (XBRL).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCustomer Accounts Receivable Concentration — Top Specialty Distributors Share of Trade AR [annual] (%) (%)Year on yearSource
FY2025Dec 31, 20258,700.0%+800.0 ptsForm 10-K (filed 2026-02-04) ↗
FY2024Dec 31, 20247,900.0%-400.0 ptsForm 10-K (filed 2026-02-04) ↗
FY2023Dec 31, 20238,300.0%-300.0 ptsForm 10-K (filed 2025-02-05) ↗
FY2022Dec 31, 20228,600.0%-500.0 ptsForm 10-K (filed 2024-02-05) ↗
FY2021Dec 31, 20219,100.0%-200.0 ptsForm 10-K (filed 2023-02-06) ↗
FY2020Dec 31, 20209,300.0%-400.0 ptsForm 10-K (filed 2022-02-07) ↗
FY2019Dec 31, 20199,700.0%-200.0 ptsForm 10-K (filed 2021-02-08) ↗
FY2018Dec 31, 20189,900.0%0.0 ptsForm 10-K (filed 2020-02-07) ↗
FY2017Dec 31, 20179,900.0%–Form 10-K (filed 2019-02-07) ↗

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Customer Accounts Receivable Concentration (%), annual FY2017–FY2025 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/conc-ar-top-cust

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?